Právní předpis byl sestaven k datu 01.05.2025.
Zobrazené znění právního předpisu je účinné od 10.12.2024.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2025
375/2024 Sb.
375
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze xxx 5. xxxxxxxx 2024
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2025
&xxxx;
Xxxxxxxxxxxx zdravotnictví podle §80 xxxx. 1 xxxx. e) zákona x. 258/2000 Sb., x xxxxxxx xxxxxxxxx xxxxxx x o xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2025:
1. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování
1a) kombinovaná xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), tetanu, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx b (DTaPHibVHBIPV)
Po xxxxxxxxxxxx 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 mezinárodních xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Bordetelly xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (PT)1 25 xxxxxxxxxx
Xxxxxxxxx haemagglutininum filamentosum (XXX)1 25 mikrogramů
Pertactinum (XXX)1 8 mikrogramů
Antigenum xxxxxxxxx xxxxxxxxxxx B (XXx)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx (XXX)
xx xxx 1 (kmen Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae typus x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas) 10 xxxxxxxxxx
xxxx. xxx xxxxxx. xxxxxxxx xxxx xxxxx xxxxxxx přibližně 25 xxxxxxxxxx
1 adsorbováno xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Al(OH)3) 0,5 xxxxxxxxx Al3+
2 vyrobeno xxxxxxxxxxxxx XXX technologií xx xxxxxxx kvasinkových xxxxx (Xxxxxxxxxxxxx cerevisiae)
3 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX)2,4 (30 Lf)
Tetani xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (IU)3,4 (10 Xx)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (inaktivovaný)5
typus 1 (Mahoney) 29 X xxxxxxxx xxxxxxxx6
xxxxx 2 (XXX-1) 7 X jednotek xxxxxxxx6
xxxxx 3 (Xxxxxxx) 26 X xxxxxxxx xxxxxxxx6
Xxxxxxxxx xxxxxxxxxxx B antigenum7 10 xxxxxxxxxx
Xxxxxxxxxx xxxxxxxxxx xxxx B xxxxxxxxxxxxxxx (Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 12 xxxxxxxxxx coniugatum xxx xxxxxx xxxxxxxx 22-36 xxxxxxxxxx
1 Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Xx3+)
2 Xxxx xxxxxx mez xxxxxxxxxxxxx (p = 0,95) x xx xxxx xxx 30 XX xxxx xxxxxxx xxxxxxx
3 Jako xxxxxx xxx xxxxxxxxxxxxx (p = 0,95)
4 Xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxx imunogenity
5 Xxxxxxxxxxx xx Xxxx xxxxxxx
6 Xxxx xxxxxxxx xxxxxxxx xxxx xxxxx xxxxxx xxxx xx, která xxxx xxxxx xxxxxxxxx xxxx 40-8-32 X xxxxxxxx xxxxxxxx xxx xxxxx xxxx 1, 2 x 3, xxx měření jinou xxxxxxx imunochemickou xxxxxxx
7 xxxxxxxx rekombinantní DNA xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx proti záškrtu, xxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx komponenta), hepatitidě X (xXXX), xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx) x xxxxxxxxxxx xxxxxxx xxxxx Xxxxxxxxxxx xxxx x (adsorbovaná)
Jedna xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 20 XX6
Xxxxxx xxxxxxxxxx1 ne xxxx xxx 40 XX6
Xxxxxxxx Xxxxxxxxxxx pertusis1
Pertussis anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (XXX) 3 xxxxxxxxxx
Xxxxxxxx typi 2 xx 3 (XXX) 5 mikrogramů
Antigenum tegiminis xxxxxxxxxxx X 2,3 10 mikrogramů
Virus xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx5
Xxxxx 2 (XXX-1) 8 D xxxxxxxx xxxxxxxx5
Xxxxx 3 (Saukett) 32 X jednotek xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx xxxxx x
(Xxxxxxxxxxxxxxxxxxx phosphas) 3 xxxxxxxxxx xxxxxxxxxx xxx xxxxxxxxx meningococci xxxxx b2 50 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 xx Al3+)
2 adsorbováno xx hydratovaný xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3 vyrobeno xxxxxxxxxxxxx XXX xxxxxxxxxxx x kvasinkových xxxxxxx Xxxxxxxxxxxxx cerevisiae
4 xxxxxxxxx xx Xxxx xxxxxxx
5 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx stanovené xxxxxxx xxxxxxxxxxxxxx metodou
6 xxxx xxxxxxxxxxxx aktivita stanovená xxxxxxxxxxxx xxxxxxxxxxx
1x) xxxxxxxx xxxxx proti záškrtu, xxxxxxxx kašli (acelulární xxxxx), xxxxxx (XXxX)
Xxxxx xxxxx (0,5 xx) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx anatoxinum* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (PT) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69xX) 8 xxxxxxxxxx
* xxxxxxxxxxx xx xxxxxxxx xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx) se sníženým xxxxxxx xxxxxxxx (Tdap)
Jedna xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 IU* (2 Xx)
Xxxxxx xxxxxxxxxx - Minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx na fosforečnan xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
* Xxxx spodní xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx v Xxxxxxxxx xxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx a dávivému xxxxx (xxxxxxxxxx komponenta) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 ne méně xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (IU) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (X1(XX)3) 0,3 xxxxxxxxx Xx3+ a xxxxxxxxxxx xxxxxxx (AlPO4) 0,2 xxxxxxxxx Al3+
1c) xxxxxxxx xxxxx proti xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx b:
Po rekonstituci 1 xxxxx (0,5 xx) obsahuje:
Haemophilus xxxxxxxxxx xxxxx b póly xxxxxxxxxxx 10 xxxxxxxxxx
xxxxxxxxxxx x xxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx 25 mikrogramů
1d) xxxxxxxx látka proti xxxxxx:
Xxxxx xxxxx obsahuje:
Tetani xxxxxxxxxx - min. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidč X x xxxxxx formuli:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 10 xxxxxxxxxx
1x) očkovací xxxxx proti virové xxxxxxxxxx X x xxxxxxx xxxxxxx
Xxxxx dávka xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám:
dávka rekonstituované xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx pro buněčnou xxxxxxx503
Xxxxxxxx virus xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx buňkách (XXX-5)
3 50% infekční xxxxx xxxxxxx kultury
NEBO
1ga) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Edmonston) xx xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxx Xxxx™, hladina X) xx xxxx xxx 12,5x103 CCID50*
Virus xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Wistar XX 27/3) xx méně xxx 1x103 CCID50*
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2 vyrobeno xx xxxxxxxx xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Mahoney) ... 29 xxxxxxxxxxx X xxxxxxxx**
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ... 7 antigenních X xxxxxxxx**
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ) ... 26 xxxxxxxxxxx X xxxxxxxx**
* Xxxxxxxxxxx xx XXXX xxxxxxx
** Xxxx xxxxxxxx xxxxxxxx xxxx xxxxx xxxxxx xxxx xx, která xxxx xxxxx xxxxxxxxx xxxx 40-8-32 D jednotek xxxxxxxx pro xxxxx xxxx 1, 2 x 3, xxx xxxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx metodou
1ch) xxxxxxxxxxx xxxxxxxx látka proti xxxxxxxxxxxxx xxxxxxxx
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 1 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 3 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 4 1,2 2,2 µg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 5 1,2 2,2 µg
polysacharid xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 6X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 6B 1,2 4,4 µg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7F 1,2 2,2 µg
polysacharid xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 8 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 9 X 1,2 2,2 µx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 10X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 12X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 14 1,2 2,2 µx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 15X 1,2 2,2 µx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 18X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 22X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 23X 1,2 2,2 µx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 33X 1,2 2,2 µx
1 Konjugován x xxxxxx xxxxxxxxx XXX197 (xxxxxxxxx 51 µx xx xxxxx)
2 Xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 mg hliníku xx xxxxx)
XXXX
1xxx) xxxxxxxx xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxxxxx schématu:
1chaa) konjugovaná xxxxxxxx xxxxx obsahuje:
Streptococci xxxxxxxxxx xxxxxxxx 11,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx serotypi 31,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 41,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 51,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 6X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6X1,2 xxxxxxxxxxxxxxx 4,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 7X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 9X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 141,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 18X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 19X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 22X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 23X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 33F1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
1 Xxxxxxxxxx x xxxxxxxxxxx xxxxxxx XXX197, CRM197 xx netoxická xxxxxx xxxxxxxxxxxx xxxxxx (xxxxxxxxxxxxx x Xxxxxxxxxxxxxxx diphtheriae X7) rekombinantně xxxxxxxxxxxxx x Pseudomonas xxxxxxxxxxx
2 Xxxxxxxxxx xx xxxxxxxx xxxxxxxxxxx hlinitý
A
1chab) xxxx xxxxxxxxxxx očkovací xxxxx xxxxxxxx:
xx 25 mikrogramech xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12X, 14, 15X, 17F, 18X, 19X, 19A, 20, 22X, 23F, 33X
XXXX
1xxx) očkovací xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxxx) konjugovaná očkovací xxxxx obsahuje:
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 11 2,2µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx x xxxxxx proteinem CRM197 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 xx xxxxxxx)
X
1xxxx) xxxx xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9V, 10X, 11X, 12F, 14, 15B, 17X, 18X, 19F, 19A, 20, 22X, 23F, 33X
1x) xxxxxxxx xxxxx xxxxx záškrtu, dávivému xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná forma):
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - xx xxxx než 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1-&xxxx; xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx pertussis xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 mikrogramů
Pertaktin1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (kmen Xxxxxxx)2 40 D xxxxxxxx antigenu
typus 2 (xxxx XXX-1)2 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)2 32 D jednotek xxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid hlinitý (Xx(XX)3) 0,3 miligramu Xx3+ x fosforečnan xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx VERO xxxxxxx
XXXX
1xx) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx dávka (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx minimálně 2 XX1 (2 Lf)
Tetani xxxxxxxxxx xxxxxxxxx 20 XX1 (5 Lf)
Pertusové xxxxxxxx:
Xxxxxxxxx anatoxinum 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (inactivatum)2
typus 1 (Mahoney) 29 X xxxxxxxx xxxxxxxx3
xxxxx 2 (XXX1) 7 X jednotek xxxxxxxx3
xxxxx 3 (Saukett) 26 X xxxxxxxx xxxxxxxx3
Xxxxxxxxxxx xx fosforečnan hlinitý 1,5 mg (0,33 xx Xx3+)
1 Jako xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (p = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx popsaného x Xxxxxxxxx xxxxxxxx
2 Xxxxxxxxxxx xx Xxxx xxxxxxx
3 Tato xxxxxxxx xxxxxxxx xxxx úplně xxxxxx xxxx xx, xxxxx xxxx dříve xxxxxxxxx xxxx 40-8-32 X xxxxxxxx xxxxxxxx xxx xxxxx xxxx 1, 2 x 3, xxx xxxxxx xxxxx xxxxxxx imunochemickou xxxxxxx
* Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx měřené xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx
** Xxxxxxxxxxx xx Xxxx buňkách.
1j) xxxxxxxx látka proti xxxxxxxxxxx (BCG xxxxxxx)
1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx B xxx osoby xxxxxxxx xx xxxxxxxxxxxx programu:
Jedna xxxxx (0,5 ml) xxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 mikrogramů
1 adjuvovaný xx AS04C xxxxxxxxxx: - 3-X-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (XXX)2 50 xxxxxxxxxx
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (celkem 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx xx kultuře xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx) xxxxxxxxxxxxx XXX xxxxxxxxxxx.
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x) očkovací látka xxxxx xxxxxx hepatitidě X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x zarděnkám:
1 xxxxx xxxxxxxxxxxxxxx vakcíny (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum1 (Xxxxxxx) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Wistar XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx embryí
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx dávka tkáňové xxxxxxx
XXXX
2xx) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx rozpuštění xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (kmen Xxxxxx’ Xxxxxxxxx) ne xxxx xxx 1x103 XXXX50*
Xxxxx parotitidis1 xxxxx xxxxxxxxxx (kmen Xxxxx Xxxx™, xxxxxxx B) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx rubeolae2 xxxxx xxxxxxxxxx (xxxx Xxxxxx RA 27/3) xx xxxx xxx 1x103 CCID50*
* 50% xxxxxxxx xxxxx buněčné xxxxxxx
1 xxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx na lidských xxxxxxxxxxx xxxxxxx XX-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx A xx xxxxxxx xxx dospělé:
Virus xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx pro xxxx:
Xxxxx hepatitis A xxxxxxxxxxx
3x) očkovací xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
1 xxxxx xxxxxxxxxxxxxxx vakcíny (0,5 xx) obsahuje:
Morbillorum xxxxx xxxxxxxxxx1 (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx xxx buněčnou kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx dávka pro xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Wistar XX 27/3) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 pomnoženo xx xxxxxxxx diploidních buňkách (XXX-5)
3 50% xxxxxxxx xxxxx tkáňové xxxxxxx
XXXX
3xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx méně xxx 1x103 CCID50*
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Jeryl Lynn™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx rubeolae2 xxxxx xxxxxxxxxx (kmen Xxxxxx XX 27/3) xx xxxx než 1x1103 XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Válek, CSc., XXX, EBIR, v. x.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 375/2024 Sb. xxxxx xxxxxxxxx xxxx 10.12.2024.
Ke xxx uzávěrky nebyl xxxxx či xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx netýká xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx předpisu.